Kibathi, L., Kumar, P., Lionakis, M., Urban, A., Ferre, E., McManus, M., . . . Freeman, A. F. (2018). 1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies. Open Forum Infect Dis.
Citação norma ChicagoKibathi, Lilian, et al. "1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients With Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who Are Refractory or Intolerant to Standard Non-Intravenous Therapies." Open Forum Infect Dis 2018.
MLA引文Kibathi, Lilian, et al. "1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients With Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who Are Refractory or Intolerant to Standard Non-Intravenous Therapies." Open Forum Infect Dis 2018.